Synthesis, anticancer activity and potential application of diosgenin modified cancer chemotherapeutic agent cytarabine

• Published in: Food and chemical toxicology 2021-02, Vol.148, p.111920-111920, Article 111920
• Main Authors: Liao, Ai-Mei, Cai, Bangrong, Huang, Ji-Hong, Hui, Ming, Lee, Kyung-Ku, Lee, Kwang Youl, Chun, ChangJu
• Format: Article
• Language: English
• Subjects: Anti-cancer; Biomembrane affinity; Cytarabine; Diosgenin; Liposome
• ISSN: 0278-6915; 1873-6351
• DOI: 10.1016/j.fct.2020.111920

Diosgenin (DG), a steroidal saponin, is mainly found in yam tubers. DG and its derivatives displayed significant pharmacological activities against inflammatory, hyperlipidemia, and various cancers. DG was selected to modify the cancer chemotherapeutic agent cytarabine (Ara-C) due to its anti-tumor activities as well as lipophilicity. After characterization, the biomembrane affinity and the kinetic thermal processes of the obtained DG-Ara-C conjugate were evaluated by differential scanning calorimetry (DSC). Thin hydration method with sonication was applied to prepare the DG-Ara-C liposomes without cholesterol since the DG moiety has the similar basic structure with cholesterol with more advantages. Dynamic Light Scattering (DLS) analysis and cytotoxic analysis were employed to characterize the DG-Ara-C liposomes and investigate their biological activities, respectively. The results indicated that DG changed the biomembrane affinity of Ara-C and successfully replaced the cholesterol during the liposome preparation. The DG-Ara-C liposomes have an average particle size of around 116 nm with a narrow size distribution and revealed better anti-cancer activity against leukemia cells and solid tumor cells than that of free DG or Ara-C. Therefore, it can be concluded that DG displayed the potential application as an anti-cancer drug carrier to improve the bio-activities, since DG counted for a critical component in modulating the biomembrane affinity, preparation of liposome, and release of hydrophilic Ara-C from lipid vesicles. •Cytarabine (Ara-C) was modified by diosgenin (DG) to overcome its drawback.•Biomembrane affinity of DG-Ara-C conjugate and the processes were studied with DSC.•DG-Ara-C conjugate liposome were successfully prepared in the absence of cholesterol.•DG-Ara-C liposome obviously increased the anticancer activity compared to free Ara-C.